Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • gt_pharma gt_pharma Sep 11, 2013 8:44 AM Flag

    News: Insmed beefs up its Arikace intellectual property estate.

    INSM says it expects to receive a U.S. patent covering "an aerosolized composition of [the] novel, once-daily inhalation formulation comprising amikacin and liposomal delivery technology for the treatment of pulmonary infections."
    The company also says the European Patent Office intends to grant a patent covering Arikace's formulation "for the treatment of pulmonary infections in CF patients."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
25.69+0.56(+2.23%)Aug 28 4:00 PMEDT